March/April 2023

Feature

Research Reports

Bone-Modifying Agent Utilization: An Analysis in Patients With Metastatic Cancer and Bone Involvement at an NCI-Designated Cancer Center

04/12/2023

Poorni M. Manohar, MD

Kyle E. Bastys

Micah Tratt

Julie Gralow, MD, FACP, FASCO

Keith D. Eaton, MD, PhD

Manohar et al investigate the cost of utilizing bone-modifying agents in the treatment of patients with metastatic cancer and bone involvement at a National Cancer Institute–designated cancer center.

Manohar et al investigate the...

04/12/2023

Journal of Clinical Pathways

Perspectives

Creating an Enabling Environment for Specialty Alternative Payment Models: A Potential Role for Philanthropy

04/12/2023

Elizabeth Shaughnessy, MA

Lindee Goh, PhD

Joel Ang, DPM, MS

Elizabeth Shaughnessy and colleagues discuss how philanthropic support may be a helpful and overlooked resource to facilitate a better enabling environment for specialty APMs.

Elizabeth Shaughnessy and...

04/12/2023

Journal of Clinical Pathways

OCPC: In Session

Patient Perspectives About Cancer Clinical Pathways and Care Coordination

04/11/2023

Deborah E. Collyar

Deborah E. Collyar discusses how patients feel through their cancer experience and suggests ways to incorporate important components like social determinants of health; diversity, equity, and inclusion strategies; and cost considerations so...

Deborah E. Collyar discusses how...

04/11/2023

Journal of Clinical Pathways

Department

Clinical Pathways Forum

A Discussion on the Development of a Clinical Decision Support Tool for the Management of Uncontrolled Cancer Symptoms

04/12/2023

Mishellene McKinney, MHA, RN, OCN—Column Editor

For the January 2023 Clinical Pathways Forum, representatives from Dana-Farber Cancer Institute and Elimu Informatics discussed the development of a clinical decision support tool to help the management of uncontrolled symptoms in patients...

For the January 2023 Clinical...

04/12/2023

Journal of Clinical Pathways

Column

Trending From ACCC

Findings From a Multicancer Early Detection Survey

04/12/2023

This article describes the findings from a 2022 Association of Community Cancer Centers (ACCC) survey and focus groups with ACCC members to explore attitudes, beliefs, and concerns related to MCED and the capacity to integrate this testing...

This article describes the...

04/12/2023

Journal of Clinical Pathways

Editor's Page

Pathways That Deliver the Best Patient Care

04/12/2023

Winston Wong, PharmD, Editor-in-Chief

Editor-in-Chief, Winston Wong, PharmD, provides insights on how creating flexible clinical pathways based on medical evidence and patient needs and desires can provide optimal care at the right time.

Editor-in-Chief, Winston Wong,...

04/12/2023

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

March/April 2023

Feature

Department

Column

Current Issue

Special Reports

Subscribe

April 2023 Volume 9 Issue 2

Specialties

Events

Year Round Education

HMP Global Products